Pre-clinical screening of drugs using the mdx mouse
- 1 June 2000
- journal article
- Published by Elsevier in Neuromuscular Disorders
- Vol. 10 (4-5) , 235-239
- https://doi.org/10.1016/s0960-8966(99)00126-1
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Elevated basic fibroblast growth factor in the serum of patients with Duchenne muscular dystrophyAnnals of Neurology, 1994
- The Molecular Basis of Muscular Dystrophy in the mdx Mouse: a Point MutationScience, 1989
- Randomized, Double-Blind Six-Month Trial of Prednisone in Duchenne's Muscular DystrophyNew England Journal of Medicine, 1989
- THE mdx MOUSE SKELETAL MUSCLE MYOPATHY: I. A HISTOLOGICAL, MORPHOMETRIC AND BIOCHEMICAL INVESTIGATIONNeuropathology and Applied Neurobiology, 1988
- Negative immunostaining of Duchenne muscular dystrophy(DMD) and mdx muscle surface membrane with antibody against synthetic peptide fragment predicted from DMD cDNA.Proceedings of the Japan Academy, Series B, 1988
- Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individualsCell, 1987
- A role for collagen in the pathogenesis of muscular dystrophy?Nature, 1980
- PREDNISONE IN DUCHENNE MUSCULAR DYSTROPHYThe Lancet, 1974
- Considerations About a Possible Role Played by Connective Tissue Proliferation and Vascular Disturbances in the Pathogenesis of Progressive Muscular DystrophyEuropean Neurology, 1968
- Human Muscular Dystrophy as an Aberration of the Connective TissueNature, 1959